Cite
HARVARD Citation
Lin, S. et al. (n.d.). OP22 Antibody decay, T cell immunity and breakthrough infections following SARS-CoV-2 vaccination in infliximab- and vedolizumab-treated patients. Journal of Crohn's and colitis. pp. i023-i025. [Online].